Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications

Abstract Background Idiopathic Pulmonary Fibrosis is a chronic, progressive interstitial lung disease for which there is no cure. However, lung function decline, hospitalizations, and mortality may be reduced with the use of the antifibrotic medications, nintedanib and pirfenidone. Historical outcom...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Bryan T. Kelly, Viengneesee Thao, Timothy M. Dempsey, Lindsey R. Sangaralingham, Stephanie R. Payne, Taylor T. Teague, Teng Moua, Nilay D. Shah, Andrew H. Limper
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2021-07-01
Edice:	BMC Pulmonary Medicine
Témata:	Idiopathic pulmonary fibrosis Antifibrotics Hospitalization Critical care Mechanical ventilation
On-line přístup:	https://doi.org/10.1186/s12890-021-01607-2
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!